Project: BG16RFOP002-1.005-0150, “Innovation and Development in Neopharm Bulgaria Ltd.”
Major objective: Promoting innovation and research at Neopharm Bulgaria Ltd.
Beneficiary: Neopharm Bulgaria Ltd.
Partner: Institute of Microbiology “Stefan Angelov” – Bulgarian Academy of Sciences
Total value: BGN 436 038.00, of which BGN 320 514.70 grant, as follows: BGN 272 437.50 European and BGN 48 077.20 national co-financing
Start: 16.11.2018
End: 16.11.2020
Major objective: Promoting innovation and research at Neopharm Bulgaria Ltd.
Beneficiary: Neopharm Bulgaria Ltd.
Partner: Institute of Microbiology “Stefan Angelov” – Bulgarian Academy of Sciences
Total value: BGN 436 038.00, of which BGN 320 514.70 grant, as follows: BGN 272 437.50 European and BGN 48 077.20 national co-financing
Start: 16.11.2018
End: 16.11.2020
Проект: BG16RFOP002-2.077-0600
Primary objective: Supporting medium-sized enterprises to overcome the economic consequences of the COVID-19 pandemic, Providing operating capital to Bulgarian medium-sized enterprises to cope with the consequences of the COVID-19 pandemic.
Beneficiary: Neopharm Bulgaria Ltd.
Total value: BGN 150 000.00, of which BGN 127 500.00 European and BGN 22 500.00 national funding.
Start date: 01.02.2021.
End: 01.05.2021.
Primary objective: Supporting medium-sized enterprises to overcome the economic consequences of the COVID-19 pandemic, Providing operating capital to Bulgarian medium-sized enterprises to cope with the consequences of the COVID-19 pandemic.
Beneficiary: Neopharm Bulgaria Ltd.
Total value: BGN 150 000.00, of which BGN 127 500.00 European and BGN 22 500.00 national funding.
Start date: 01.02.2021.
End: 01.05.2021.
Project: Rebuilding SMEs through energy efficiency improvements
Procedure: BG16RFOP002-6.002
Beneficiary: Neopharm Bulgaria Ltd.
Start date: 16.09.2022
End: 16.03.2023
Total value: 287 500.00 BGN.
Grant: BGN 143 750.00 representing 100% European Regional Development Fund under REACT-EU
Objective: To improve energy efficiency in the Company by installing new air conditioning chambers.
Procedure: BG16RFOP002-6.002
Beneficiary: Neopharm Bulgaria Ltd.
Start date: 16.09.2022
End: 16.03.2023
Total value: 287 500.00 BGN.
Grant: BGN 143 750.00 representing 100% European Regional Development Fund under REACT-EU
Objective: To improve energy efficiency in the Company by installing new air conditioning chambers.